Nov 10 (Reuters) - Biolase Inc BIOL.O :
* BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN
THIRD
QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE
* Q3 REVENUE ROSE 26 PERCENT TO $12.0 MILLION
* QTRLY LOSS PER SHARE $1.10
* EXPECTS Q4 NET REVENUE TO EXCEED $13.0 MILLION
* CO INCREASING ITS 2022 FULL YEAR REVENUE GUIDANCE, FY
REVENUE TO
INCREASE AT LEAST 20% FROM 2021 LEVELS
* Q3 REVENUE VIEW $10.7 MILLION -- REFINITIV IBES DATA
* Q4 REVENUE VIEW $12.6 MILLION -- REFINITIV IBES DATA
* FY2022 REVENUE VIEW $45.6 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn8HgFJja
Further company coverage: BIOL.O
((Reuters.Briefs@thomsonreuters.com;;))